HEALTHY EXTRACTS INC.: Healthy Extracts Sees First Half 2026 Net Revenue Up More Than 93% to Record $3.6 Million+
Healthy Extracts Inc. (OTCQB:HYEX) said it expects Q2 2026 net revenue to exceed $2.0 million, up more than 112% sequentially and 129% year over year. For the first half ended June 30, 2026, it expects net revenue above $3.6 million, up over 93% from H1 2025, citing the Gummy USA merger and the Imaraïs Beauty acquisition.
How this was made
The 30-second read
Why it matters
The main tradable element is forward-looking revenue guidance for Q2 and first-half 2026, plus operational detail on a nearly 4 million gummy initial order and shipping to 4,000+ store locations, both attributed to the Imaraïs integration.
Market read
For HYEX, the article provides specific revenue targets and ties them to newly acquired/partnered product lines and retail distribution momentum, which can influence near-term sentiment and positioning ahead of reported results.
What to watch
The piece does not quantify gross margin, cash burn, working-capital needs, or integration costs from the Gummy USA merger and Imaraïs acquisition, which are critical for translating topline growth into shareholder value.
Background
Healthy Extracts is an OTC nutraceutical and precision-dose gummy manufacturer, and the article frames 2026 performance as driven by its October 2025 Gummy USA merger and May 2026 acquisition of Imaraïs Beauty.
Ticker impact
Healthy Extracts (OTCQB:HYEX) guides Q2 net revenue above $2.0M and first-half net revenue above $3.6M, citing the Imaraïs acquisition and Gummy USA merger.
Likely positive bias for HYEX on increased visibility into revenue run-rate, though OTC microcap liquidity and execution risk may limit follow-through.
The text provides concrete forward-looking revenue figures and links them to specific deal milestones (acquisition, manufacturing partnership evolving into acquisition, and a nearly 4M-gummy initial order shipping to 4,000+ locations). However, it is still a forecast/PR rather than audited results, and no valuation or balance-sheet details are provided.
Market effects
Supports the broader nutraceutical and functional gummy manufacturing consolidation theme, highlighting B2B manufacturing scale-up and retail distribution expansion as key growth levers.
Primarily US retail distribution expansion (Target, Ulta, Sprouts) could modestly lift demand for contract manufacturing in the US health and beauty supply chain.
Imaraïs is described as having worldwide retail and online reach, implying potential international distribution upside if execution matches the acquisition thesis.
Counterpoint
Revenue targets may be optimistic given the article’s reliance on deal synergies and an initial order; without confirmation of repeat orders and margins, the guidance could disappoint.
Key entities
- companyHealthy Extracts Inc.
OTCQB:HYEX nutraceutical formulations and precision-dose gummy manufacturing company issuing 2026 revenue outlook and integration updates.
- companyImaraïs Beauty
Plant-based ingestible beauty and wellness brand founded by Sommer Ray and Aaron Hefter, whose partnership evolved into an acquisition by Healthy Extracts.
- companyGummy USA
Wholly owned subsidiary of Healthy Extracts referenced as the platform for precision-dosed gummy manufacturing and the October 2025 merger synergy.
- personSommer Ray
Media personality associated with Imaraïs Beauty’s founding and brand profile.
- personAaron Hefter
Supplement industry veteran associated with Imaraïs Beauty’s founding.
